Devices/Safety Alert·openFDA/device

CapSureFix Novus Lead MRI SureScan (Medtronic Puerto Rico Villalba) — Malfunction

MediumPublished Jul 31, 2026· AI-analyzed Aug 11, 2026View original FDA source

AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.

What happened

A malfunction event was reported regarding the CapSureFix Novus Lead MRI SureScan manufactured by Medtronic Puerto Rico Villalba. The source documents this as a device malfunction but does not specify the exact nature of the failure mode.

Who it affects

This affects the manufacturer, Medtronic Puerto Rico Villalba, and potentially healthcare providers or clinical operations teams managing patients with these specific implantable leads.

Why it matters

The reporting of a malfunction for an implantable MRI-conditional lead suggests a potential risk to device integrity or performance. For regulatory professionals, this indicates a need for heightened monitoring of field performance and may necessitate a review of the device's risk management file if the malfunction frequency exceeds established thresholds.

Practical takeaway

Quality teams should review post-market surveillance data for the CapSureFix Novus Lead MRI SureScan to identify any emerging trends in malfunction reports. Regulatory and clinical departments should ensure that all internal reporting mechanisms for implantable lead malfunctions remain compliant with MDR requirements.

FDA source material

Event type: Malfunction. Device: CapSureFix Novus Lead MRI SureScan by Medtronic Puerto Rico Villalba.

Open in openFDA / FDA.gov

AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.

CapSureFix Novus Lead MRI SureScan (Medtronic Puerto Rico Villalba) — Malfunction

More from Devices